Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for murine NKG2D

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4079-4083

  Carayannopoulos, Leonidas N ^a   Naidenko, Olga V ^a   Fremont, Daved H ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MURINE UL16 BINDING PROTEIN LIKE TRANSCRIPT 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL DESTRUCTION; CELL SURFACE; CYTOLYSIS; LIGAND BINDING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0037108353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4079     Document Type: Article

References (30)

1. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119.
2. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123.
3. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by γ-δ T cells. Science 294:605.
4. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255.
5. Tieng, V., C. Bouguenec, L. du Merle, P. Bertheau, P. Desreumaux, A. Janin, D. Charron, and A. Toubert. 2002. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA 99:2977.
6. Binstadt, B. A., K. M. Brumbaugh, and P. J. Leibson. 1997. Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197.
7. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
8. Pende, D., C. Cantoni, P. Rivera, M. Vitale, R. Castriconi, S. Marcenaro, M. Nanni, R. Biassoni, C. Bottino, A. Moretta, and L. Moretta. 2001. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 31:1076.
9. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727.
10. Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class 1-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98:11521.
11. Radosavljevic, M., B. Cuillerier, M. J. Wilson, O. Clement, S. Wicker, S. Gilfillan, S. Beck, J. Trowsdale, and S. Bahram. 2002. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 79:114.
12. Hankey, K. G., C. B. Drachenberg, J. C. Papadimitriou, D. K. Klassen, B. Philosophe, S. T. Bartlett, V. Groh, T. Spies, and D. L. Mann. 2001. MIC expression in renal and pancreatic allografts. Transplantation 73:304.
13. Cerwenka, A., A. B. H. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721.
14. Zou, Z., M. Nomura, Y. Takihara, T. Yasunaga, and K. Shimada. 1996. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J. Biochem. 119:319.
15. Malarkannan, S., P. P. Shih, P. A. Eden, T. Horng, A. R. Zuberi, G. Christianson, D. Roopenian, and N. Shastri. 1998. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161:3501.
16. Lennon, G., C. Auffray, M. Polymeropoulos, and M. B. Soares. 1996. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33:151.
17. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier, D. M. Gorman, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:324.
18. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063.
19. Kelley, L. A., R. M. MacCallum, and M. J. Sternberg. 2000. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299: 499.
20. Nielsen, H., J. Engelbrecht, S. Brunak, and G. von Heijne. 1997. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1.
21. Buloz, D., and J. Kronegg. 1999. DGPI, Geneva, Switzerland.
22. Eisenhaber, B., P. Bork, and F. Eisenhaber. 1999. Prediction of potential GPI-modification sites in proprotein sequences. J. Mol. Biol. 292:741.
23. Carayannopoulos, L. N., O. V. Naidenko, J. Kinder, E. L. Ho, D. H. Fremont, and W. M. Yokoyama. 2002. Ligands for NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 32:597.
24. Koo, G. C., and J. R. Peppard. 1984. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 3:301.
25. Radaev, S., B. Rostro, A. G. Brooks, M. Colonna, and P. D. Sun. 2001. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15:1039.
26. Li, P., G. McDermott, and R. K. Strong. 2002. Crystal structures of RAE-1β and its complex with the activating immunoreceptor NKG2D. Immunity 16:77.
27. O'Callaghan, C. A., A. Cerwenka, B. E. Willcox, L. L. Lanier, and P. J. Bjorkman. 2001. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity 15:201.
28. Klein, J., Y. Satta, C. O'Huigin, and N. Takahata. 1993. The molecular descent of the major histocompatibility complex. Annu. Rev. Immunol. 11:269.
29. Khakoo, S. I., R. Rajalingam, B. P. Shum, K. Weidenbach, L. Flodin, D. G. Muir, F. Canavez, S. L. Cooper, N. M. Valiante, L. L. Lanier, and P. Parham. 2000. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12:687.
30. Krmpotic, A., D. H. Busch, I. Bubic, F. Gebhhardt, H. Hengel, M. Hasan, A. A. Scalzo, U. H. Koszinowski, and S. Jonjic. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8 T cells and NK cells in vivo. Nat. Immunol. 3:529.